Search Results - "Mason, Kathy"

Refine Results
  1. 1

    The Limitations of Model-Based Experimental Design and Parameter Estimation in Sloppy Systems by White, Andrew, Tolman, Malachi, Thames, Howard D, Withers, Hubert Rodney, Mason, Kathy A, Transtrum, Mark K

    Published in PLoS computational biology (01-12-2016)
    “…We explore the relationship among experimental design, parameter estimation, and systematic error in sloppy models. We show that the approximate nature of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer by Vichaya, Elisabeth G, Vermeer, Daniel W, Christian, Diana L, Molkentine, Jessica M, Mason, Kathy A, Lee, John H, Dantzer, Robert

    Published in Psychoneuroendocrinology (01-05-2017)
    “…Highlights • Tumor inflammation is associated with increased liver and brain inflammation. • The tumor-induced a behavioral phenotype resembling mild fatigue…”
    Get full text
    Journal Article
  5. 5
  6. 6

    MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation by Wang, Li, Mason, Kathy A., Ang, K. Kian, Buchholz, Thomas, Valdecanas, David, Mathur, Anjili, Buser-Doepner, Carolyn, Toniatti, Carlo, Milas, Luka

    Published in Investigational new drugs (01-12-2012)
    “…Summary The poly-(ADP-ribose) polymerase (PARP) inhibitor, MK-4827, is a novel potent, orally bioavailable PARP-1 and PARP-2 inhibitor currently in phase I…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Theoretical and methodological considerations in evaluating large-scale health information technology change programmes by Cresswell, Kathrin, Sheikh, Aziz, Franklin, Bryony Dean, Krasuska, Marta, Nguyen, Hung The, Hinder, Susan, Lane, Wendy, Mozaffar, Hajar, Mason, Kathy, Eason, Sally, Potts, Henry W W, Williams, Robin

    Published in BMC health services research (27-05-2020)
    “…Attempts to achieve digital transformation across the health service have stimulated increasingly large-scale and more complex change programmes. These…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Mitigation and Treatment of Radiation-Induced Thoracic Injury With a Cyclooxygenase-2 Inhibitor, Celecoxib by Hunter, Nancy R., MS, Valdecanas, David, BS, Liao, Zhongxing, MD, Milas, Luka, MD, Thames, Howard D., PhD, Mason, Kathy A., MS

    “…Purpose To test whether a cyclooxygenase-2 inhibitor (celecoxib) could reduce mortality resulting from radiation-induced pneumonitis. Methods and Materials…”
    Get full text
    Journal Article
  11. 11

    Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses by Sheu, Tommy, Molkentine, Jessica, Transtrum, Mark K, Buchholz, Thomas A, Withers, Hubert Rodney, Thames, Howard D, Mason, Kathy A

    Published in Radiotherapy and oncology (01-10-2013)
    “…Abstract Purpose To test the appropriateness of the linear-quadratic (LQ) model to describe survival of jejunal crypt clonogens after split doses with variable…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Formative independent evaluation of a digital change programme in the English National Health Service: study protocol for a longitudinal qualitative study by Cresswell, Kathrin, Sheikh, Aziz, Dean Franklin, Bryony, Krasuska, Marta, Nguyen, Hung, Hinder, Susan, Lane, Wendy, Mozaffar, Hajar, Mason, Kathy, Eason, Sally, Potts, Henry, Williams, Robin

    Published in BMJ open (08-10-2020)
    “…IntroductionMany countries are launching large-scale, digitally enabled change programmes as part of efforts to improve the quality, safety and efficiency of…”
    Get full text
    Journal Article
  14. 14

    The Withers archive: Online availability of rod Wither’s data by Thames, Howard D, Hunter, N.R, Mason, Kathy A

    Published in Radiotherapy and oncology (01-12-2016)
    “…Abstract The contents of the lab notebooks of H.R. Withers have been digitized and stored as 23 excel files, a total of approximately 45 megabytes. A procedure…”
    Get full text
    Journal Article
  15. 15

    A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer by Lin, Steven H, Zhang, Jing, Giri, Uma, Stephan, Clifford, Sobieski, Mary, Zhong, Ling, Mason, Kathy A, Molkentine, Jessica, Thames, Howard D, Yoo, Stephen S, Heymach, John V

    Published in Journal of thoracic oncology (01-07-2014)
    “…Traditional clonogenic survival and high throughput colorimetric assays are inadequate as drug screens to identify novel radiation sensitizers. We developed a…”
    Get more information
    Journal Article
  16. 16

    Driving digital health transformation in hospitals: a formative qualitative evaluation of the English Global Digital Exemplar programme by Krasuska, Marta, Williams, Robin, Sheikh, Aziz, Franklin, Bryony, Hinder, Susan, TheNguyen, Hung, Lane, Wendy, Mozaffar, Hajar, Mason, Kathy, Eason, Sally, Potts, Henry, Cresswell, Kathrin

    Published in BMJ health & care informatics (01-12-2021)
    “…BackgroundThere is currently a strong drive internationally towards creating digitally advanced healthcare systems through coordinated efforts at a national…”
    Get full text
    Journal Article
  17. 17

    CpG plus radiotherapy: a review of preclinical works leading to clinical trial by Mason, Kathy A, Hunter, Nancy R

    Published in Frontiers in oncology (2012)
    “…Studies performed three decades ago in our laboratory supported the hypothesis that radiation efficacy may be augmented by bacterial extracts that stimulate…”
    Get full text
    Journal Article
  18. 18

    In Vivo Enhancement of Tumor Radioresponse by C225 Antiepidermal Growth Factor Receptor Antibody by MILAS, L, MASON, K, HUNTER, N, PETERSEN, S, YAMAKAWA, M, KIAN ANG, MENDELSOHN, J, ZHEN FAN

    Published in Clinical cancer research (01-02-2000)
    “…Overexpression of epidermal growth factor receptor (EGFR) has been correlated with tumor resistance to cytotoxic agents, including radiation (T. Akimoto et…”
    Get full text
    Journal Article
  19. 19

    Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer by Brooks, Colin, Sheu, Tommy, Bridges, Kathleen, Mason, Kathy, Kuban, Deborah, Mathew, Paul, Meyn, Raymond

    Published in Radiation oncology (London, England) (11-09-2012)
    “…Many prostate cancers demonstrate an increased expression of growth factor receptors such as vascular endothelial growth factor receptor (VEGFR) and platelet…”
    Get full text
    Journal Article
  20. 20

    Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation by Milas, Luka, M.D., Ph.D, Fang, Fu-Min, M.D, Mason, Kathy A., M.Sc, Valdecanas, David, B.S, Hunter, Nancy, M.Sc, Koto, Masashi, M.D, Ang, K. Kian, M.D., Ph.D

    “…Purpose: C225 strongly enhances tumor radioresponse when given concurrently with radiotherapy. We investigated whether additional therapeutic benefit could be…”
    Get full text
    Journal Article